Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chlebowski

Showing results (41-50 of 379) with videos related to

Pageof 38
Sort By:
Cancer|January 15, 1989
Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administrationM Grosvenor, L Bulcavage, R T Chlebowski
Breast Cancer Research and Treatment|January 15, 2018
Breast cancer survivorship: state of the scienceKathy Pan, Arti Hurria, Rowan T Chlebowski
Breast Cancer Research and Treatment|September 29, 2021
Sleep medication use and risk of fractures in breast cancer survivorsReina Haque, Rowan T Chlebowski, LieHong Chen
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
Adherence to endocrine therapy in breast cancer adjuvant and prevention settingsRowan T Chlebowski, Jisang Kim, Reina Haque
Investigational New Drugs|January 1, 1994
5-fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinomaP J Loehrer, D Harry, R T Chlebowski
Cancer Research|April 1, 1990
Relationship of hepatic glucose production to growth hormone and severity of malnutrition in a population with colorectal carcinomaJ A Tayek, L Bulcavage, R T Chlebowski
JCO Oncology Practice|July 28, 2021
Breast Cancer Prevention: Time for ChangeRowan T Chlebowski, Aaron K Aragaki, Kathy Pan
Current Treatment Options in Oncology|June 12, 2002
Management of bloody nipple dischargeHernan I Vargas, Lina Romero, Rowan T Chlebowski
Cancer|January 1, 1985
Metabolic abnormalities in the cancer patientD Heber, L O Byerly, R T Chlebowski
Lancet (London, England)|August 1, 1987
Effect of hydrazine sulphate on whole-body protein breakdown measured by 14C-lysine metabolism in lung cancer patientsJ A Tayek, D Heber, R T Chlebowski
Pageof 38

Showing results (41-50 of 379) with videos related to

Sort By:
Pageof 38
Cancer|January 15, 1989
Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administrationM Grosvenor, L Bulcavage, R T Chlebowski
Breast Cancer Research and Treatment|January 15, 2018
Breast cancer survivorship: state of the scienceKathy Pan, Arti Hurria, Rowan T Chlebowski
Breast Cancer Research and Treatment|September 29, 2021
Sleep medication use and risk of fractures in breast cancer survivorsReina Haque, Rowan T Chlebowski, LieHong Chen
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
Adherence to endocrine therapy in breast cancer adjuvant and prevention settingsRowan T Chlebowski, Jisang Kim, Reina Haque
Investigational New Drugs|January 1, 1994
5-fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinomaP J Loehrer, D Harry, R T Chlebowski
Cancer Research|April 1, 1990
Relationship of hepatic glucose production to growth hormone and severity of malnutrition in a population with colorectal carcinomaJ A Tayek, L Bulcavage, R T Chlebowski
JCO Oncology Practice|July 28, 2021
Breast Cancer Prevention: Time for ChangeRowan T Chlebowski, Aaron K Aragaki, Kathy Pan
Current Treatment Options in Oncology|June 12, 2002
Management of bloody nipple dischargeHernan I Vargas, Lina Romero, Rowan T Chlebowski
Cancer|January 1, 1985
Metabolic abnormalities in the cancer patientD Heber, L O Byerly, R T Chlebowski
Lancet (London, England)|August 1, 1987
Effect of hydrazine sulphate on whole-body protein breakdown measured by 14C-lysine metabolism in lung cancer patientsJ A Tayek, D Heber, R T Chlebowski
Pageof 38